| Element List | Explanation |
|---|---|
| Announcement Detail | Dr. Soliman Abdulkader Fakeeh Hospital Company ("DSFH") and its subsidiaries ("Fakeeh Care Group", "Group", "Fakeeh Care") is pleased to announce that the Board of Directors, on 4th of November 2025, has approved the initiation of negotiations to acquire a majority stake in Diagnostic Elite Company (“DE”) whereby it becomes a subsidiary of DSFH. |
This acquisition is intended to come by way of an assignment by an affiliate, Sulaiman Abdul-Qader Fakeeh Real Estate Co. (related party), of 50.01% of its investment in DE in favor of DSFH. This transaction aims to ensure that DE’s service offerings further integrate within the Group’s core healthcare platform.
This transaction is subject to the regulatory approvals and necessary procedures to complete the assignment between DSFH and Sulaiman Abdul-Qader Fakeeh Real Estate Co. (related party). Further material developments will be announced in accordance with applicable regulations.
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.